The management of irritable bowel syndrome (ibs) should be individualized to the person's symptoms and psychosocial situation, and may include offering drug treatment and behavioural interventions, if symptoms persist despite initial dietary and lifestyle advice. Management last revised in july 2025 scenario Covers the management of irritable bowel syndrome in adults in primary care. Antispasmodic drugs may be used as required for abdominal pain or spasm in irritable bowel syndrome (ibs) The national institute for health and care excellence (nice) guideline irritable bowel syndrome in adults All people with suspected ibs should be assessed for symptoms and signs of serious conditions that may present with similar clinical features to ibs such as bowel cancer, ovarian cancer or inflammatory bowel disease.
Loperamide is licensed for the symptomatic treatment of acute diarrhoea in irritable bowel syndrome (ibs) in adults aged 18 years and older Initially 4 mg, followed by 2 mg for up to five days, dose to be taken after each loose stool Maximum 16 mg per day Important aspects of prescribing information relevant to primary healthcare are covered in this section specifically for the drugs recommended in this cks topic.
OPEN
